Bergeson & Campbell, P.C.

Bergeson & Campbell, P.C. stands as a highly esteemed law firm in Washington, D.C., boasting an AV rating—the pinnacle of legal distinction. This firm specializes in the regulation and approval processes for both conventional and nanoscale chemical products across various sectors including industrial, agricultural, and specialty chemicals. Their expertise encompasses a comprehensive range of matters such as TSCA compliance issues, FIFRA/FQPA regulations, FDA approvals for medical devices and products along with registration disputes related to data compensation. They also handle litigation regarding chemical products alongside vital business advisory services. The clientele at Bergeson & Campbell spans multiple industries—covering conventional to nanoscale chemicals; biotechnology; nanotechnology with groundbreaking innovations; pharmaceuticals alongside medical devices; diagnostic tools; fibers; paints and coatings materials; publishing industries to plastics manufacturing. The firm's representation extends beyond individual clients to encompass businesses, trade associations, and industry coalitions alike. Dedicated professionals from Bergeson & Campbell advocate on behalf of their clients before key regulatory bodies like the EPA or FDA as well as HHS agencies while engaging federal courts at all levels along with state governing organizations when necessary. Their proactive approach includes shaping business strategies — ensuring compliance is met diligently while supporting toxic tort defense efforts amid acquisitions or similar endeavors within this complex legal landscape.